All In MedTech

FDA Clearance Tracker · K142149

OXYTOTE INFINITY SERIES VIPR SYSTEMS

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Apr 17, 2015 (this decision)Source: openFDAMethods & limitations

510(k)

The decision

FDA number
K142149
Device name
OXYTOTE INFINITY SERIES VIPR SYSTEMS
Applicant location
Westlake, OH
Received
Aug 5, 2014
Decided
Apr 17, 2015
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class I
Regulation
21 CFR 868.2700

Every decision under product code ECX

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code ECX. The earliest in FDA's data is K771246, decided Jul 15, 1977.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Western/Scott Fetzer Co.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.